• Company
• New drug 'Mylotarg' for AML makes another attempt at reimb
• by Eo, Yun-Ho Jun 27, 2024 05:47am

• InterView
• ‘Leqembi enables prevention of Alzheimer's disease’
• by Son, Hyung-Min Jun 27, 2024 05:47am

• Company
• SGLT-2 diabetes drug Jardiance outsells mkt leader Forxiga
• by Nho, Byung Chul Jun 26, 2024 05:47am

• Boryung’s early release of its Lenvima generic unclear
• by Kim, Jin-Gu Jun 26, 2024 05:46am

• Company
• Another anticancer drug 'Augtyro' set to be launched in KOR
• by Eo, Yun-Ho Jun 26, 2024 05:46am

• Policy
• ‘Hypertension·hyperlipidemia generics are pricier in KOR'
• by Lee, Jeong-Hwan Jun 26, 2024 05:46am

• Company
• Returned license-outs for new drugs one after another
• by Kim, Jin-Gu Jun 26, 2024 05:46am

• Policy
• Fasenra·Idelvion, Ajovy·Emgality receive reimb in KOR
• by Lee, Jeong-Hwan Jun 25, 2024 05:47am

• Company
• Trelegy 200 Ellipta may be prescribed at tertiary hospitals
• by Eo, Yun-Ho Jun 25, 2024 05:46am

• Company
• 'Camzyos' receives DREC’s reconsideration decision
• by Eo, Yun-Ho Jun 25, 2024 05:46am